Safety and efficacy of Paxlovid in the treatment of adults with mild to moderate COVID-19 during the omicron epidemic: a multicentre study from China

CONCLUSION: Amid the Omicron outbreak, Paxlovid has proven to be a safe and effective treatment for reducing hospitalization durations for patients with mild to moderate COVID-19.PMID:38300126 | DOI:10.1080/14787210.2024.2309998

Source: Expert Review of Anti-Infective Therapy - February 1, 2024 Category: Infectious Diseases Authors: Pulin Li Ling Huang Rui Han Min Tang Guanghe Fei Daxiong Zeng Ran Wang Source Type: research